WO2025172860 - POLYENE MACROLIDE COMPOSITIONS AND USES THEREOF
National phase entry is expected:
Publication Number
WO/2025/172860
Publication Date
21.08.2025
International Application No.
PCT/IB2025/051477
International Filing Date
12.02.2025
Title **
[English]
POLYENE MACROLIDE COMPOSITIONS AND USES THEREOF
[French]
COMPOSITIONS DE MACROLIDES POLYÉNIQUES ET LEURS UTILISATIONS
Applicants **
BIOSERGEN AS
Inventors
OLESEN, Tine Kold
DEGNES, Kristin Fløgstad
MALIK, Leila
ANDERSEN, Peder Møller
SLETTA, Håvard
Priority Data
63/553,381
14.02.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3897 | |
| EPO | Filing, Examination, Granting | 57287 | |
| Japan | Filing, Examination, Granting | 4006 | |
| South Korea | Filing, Examination, Granting | 5694 | |
| USA | Filing, Examination, Granting | 20940 |
Total:
91,824
Contact Us
Abstract[English]
This invention relates to lyophilized pharmaceutical compositions that include therapeutic polyene macrolides to increase bioavailability and shelf-life of the compositions.[French]
La présente invention concerne des compositions pharmaceutiques lyophilisées qui contiennent des macrolides polyéniques thérapeutiques permettant d'augmenter la biodisponibilité et la durée de conservation des compositions.